Global Aldult CAR T-cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 97

Published Date: 29 Jul 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Aldult CAR T-cell Therapy market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Aldult CAR T-cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Aldult CAR T-cell Therapy market size and forecasts, in consumption value ($ Million), 2019-2030
Global Aldult CAR T-cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Aldult CAR T-cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Aldult CAR T-cell Therapy market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aldult CAR T-cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aldult CAR T-cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb，BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics, Cartesian Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Aldult CAR T-cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Aldult CAR T-cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    CD19
    BCMA
    Others

Market segment by Application
    Multiple Myeloma
    B-Cell Lymphoma (BCL)
    Acute Lymphoblastic Leukemia (ALL)
    Others

Market segment by players, this report covers
    Bristol Myers Squibb，BMS
    Johnson & Johnson
    Gilead Sciences
    Novartis
    JW Therapeutics
    Imunopharm Technology Co., Ltd.
    CARsgen Therapeutics
    Cartesian Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Aldult CAR T-cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Aldult CAR T-cell Therapy, with revenue, gross margin, and global market share of Aldult CAR T-cell Therapy from 2019 to 2024.
Chapter 3, the Aldult CAR T-cell Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Aldult CAR T-cell Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Aldult CAR T-cell Therapy.
Chapter 13, to describe Aldult CAR T-cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Aldult CAR T-cell Therapy by Type
        1.3.1 Overview: Global Aldult CAR T-cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Aldult CAR T-cell Therapy Consumption Value Market Share by Type in 2023
        1.3.3 CD19
        1.3.4 BCMA
        1.3.5 Others
    1.4 Global Aldult CAR T-cell Therapy Market by Application
        1.4.1 Overview: Global Aldult CAR T-cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Multiple Myeloma
        1.4.3 B-Cell Lymphoma (BCL)
        1.4.4 Acute Lymphoblastic Leukemia (ALL)
        1.4.5 Others
    1.5 Global Aldult CAR T-cell Therapy Market Size & Forecast
    1.6 Global Aldult CAR T-cell Therapy Market Size and Forecast by Region
        1.6.1 Global Aldult CAR T-cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Aldult CAR T-cell Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Aldult CAR T-cell Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Aldult CAR T-cell Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Aldult CAR T-cell Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Aldult CAR T-cell Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Aldult CAR T-cell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Bristol Myers Squibb，BMS
        2.1.1 Bristol Myers Squibb，BMS Details
        2.1.2 Bristol Myers Squibb，BMS Major Business
        2.1.3 Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Product and Solutions
        2.1.4 Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bristol Myers Squibb，BMS Recent Developments and Future Plans
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Aldult CAR T-cell Therapy Product and Solutions
        2.2.4 Johnson & Johnson Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Johnson & Johnson Recent Developments and Future Plans
    2.3 Gilead Sciences
        2.3.1 Gilead Sciences Details
        2.3.2 Gilead Sciences Major Business
        2.3.3 Gilead Sciences Aldult CAR T-cell Therapy Product and Solutions
        2.3.4 Gilead Sciences Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Gilead Sciences Recent Developments and Future Plans
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Aldult CAR T-cell Therapy Product and Solutions
        2.4.4 Novartis Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Novartis Recent Developments and Future Plans
    2.5 JW Therapeutics
        2.5.1 JW Therapeutics Details
        2.5.2 JW Therapeutics Major Business
        2.5.3 JW Therapeutics Aldult CAR T-cell Therapy Product and Solutions
        2.5.4 JW Therapeutics Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 JW Therapeutics Recent Developments and Future Plans
    2.6 Imunopharm Technology Co., Ltd.
        2.6.1 Imunopharm Technology Co., Ltd. Details
        2.6.2 Imunopharm Technology Co., Ltd. Major Business
        2.6.3 Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Product and Solutions
        2.6.4 Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Imunopharm Technology Co., Ltd. Recent Developments and Future Plans
    2.7 CARsgen Therapeutics
        2.7.1 CARsgen Therapeutics Details
        2.7.2 CARsgen Therapeutics Major Business
        2.7.3 CARsgen Therapeutics Aldult CAR T-cell Therapy Product and Solutions
        2.7.4 CARsgen Therapeutics Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 CARsgen Therapeutics Recent Developments and Future Plans
    2.8 Cartesian Therapeutics
        2.8.1 Cartesian Therapeutics Details
        2.8.2 Cartesian Therapeutics Major Business
        2.8.3 Cartesian Therapeutics Aldult CAR T-cell Therapy Product and Solutions
        2.8.4 Cartesian Therapeutics Aldult CAR T-cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Cartesian Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Aldult CAR T-cell Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Aldult CAR T-cell Therapy by Company Revenue
        3.2.2 Top 3 Aldult CAR T-cell Therapy Players Market Share in 2023
        3.2.3 Top 6 Aldult CAR T-cell Therapy Players Market Share in 2023
    3.3 Aldult CAR T-cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 Aldult CAR T-cell Therapy Market: Region Footprint
        3.3.2 Aldult CAR T-cell Therapy Market: Company Product Type Footprint
        3.3.3 Aldult CAR T-cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Aldult CAR T-cell Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Aldult CAR T-cell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Aldult CAR T-cell Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Aldult CAR T-cell Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Aldult CAR T-cell Therapy Consumption Value by Type (2019-2030)
    6.2 North America Aldult CAR T-cell Therapy Market Size by Application (2019-2030)
    6.3 North America Aldult CAR T-cell Therapy Market Size by Country
        6.3.1 North America Aldult CAR T-cell Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Aldult CAR T-cell Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Aldult CAR T-cell Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Aldult CAR T-cell Therapy Market Size by Country
        7.3.1 Europe Aldult CAR T-cell Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Aldult CAR T-cell Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Aldult CAR T-cell Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Aldult CAR T-cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Aldult CAR T-cell Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Aldult CAR T-cell Therapy Consumption Value by Type (2019-2030)
    9.2 South America Aldult CAR T-cell Therapy Consumption Value by Application (2019-2030)
    9.3 South America Aldult CAR T-cell Therapy Market Size by Country
        9.3.1 South America Aldult CAR T-cell Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Aldult CAR T-cell Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Aldult CAR T-cell Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Aldult CAR T-cell Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Aldult CAR T-cell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Aldult CAR T-cell Therapy Market Drivers
    11.2 Aldult CAR T-cell Therapy Market Restraints
    11.3 Aldult CAR T-cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Aldult CAR T-cell Therapy Industry Chain
    12.2 Aldult CAR T-cell Therapy Upstream Analysis
    12.3 Aldult CAR T-cell Therapy Midstream Analysis
    12.4 Aldult CAR T-cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Aldult CAR T-cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Aldult CAR T-cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Aldult CAR T-cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Aldult CAR T-cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Bristol Myers Squibb，BMS Company Information, Head Office, and Major Competitors
 Table 6. Bristol Myers Squibb，BMS Major Business
 Table 7. Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Product and Solutions
 Table 8. Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Bristol Myers Squibb，BMS Recent Developments and Future Plans
 Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
 Table 11. Johnson & Johnson Major Business
 Table 12. Johnson & Johnson Aldult CAR T-cell Therapy Product and Solutions
 Table 13. Johnson & Johnson Aldult CAR T-cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Johnson & Johnson Recent Developments and Future Plans
 Table 15. Gilead Sciences Company Information, Head Office, and Major Competitors
 Table 16. Gilead Sciences Major Business
 Table 17. Gilead Sciences Aldult CAR T-cell Therapy Product and Solutions
 Table 18. Gilead Sciences Aldult CAR T-cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. Novartis Company Information, Head Office, and Major Competitors
 Table 20. Novartis Major Business
 Table 21. Novartis Aldult CAR T-cell Therapy Product and Solutions
 Table 22. Novartis Aldult CAR T-cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. Novartis Recent Developments and Future Plans
 Table 24. JW Therapeutics Company Information, Head Office, and Major Competitors
 Table 25. JW Therapeutics Major Business
 Table 26. JW Therapeutics Aldult CAR T-cell Therapy Product and Solutions
 Table 27. JW Therapeutics Aldult CAR T-cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. JW Therapeutics Recent Developments and Future Plans
 Table 29. Imunopharm Technology Co., Ltd. Company Information, Head Office, and Major Competitors
 Table 30. Imunopharm Technology Co., Ltd. Major Business
 Table 31. Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Product and Solutions
 Table 32. Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. Imunopharm Technology Co., Ltd. Recent Developments and Future Plans
 Table 34. CARsgen Therapeutics Company Information, Head Office, and Major Competitors
 Table 35. CARsgen Therapeutics Major Business
 Table 36. CARsgen Therapeutics Aldult CAR T-cell Therapy Product and Solutions
 Table 37. CARsgen Therapeutics Aldult CAR T-cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. CARsgen Therapeutics Recent Developments and Future Plans
 Table 39. Cartesian Therapeutics Company Information, Head Office, and Major Competitors
 Table 40. Cartesian Therapeutics Major Business
 Table 41. Cartesian Therapeutics Aldult CAR T-cell Therapy Product and Solutions
 Table 42. Cartesian Therapeutics Aldult CAR T-cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. Cartesian Therapeutics Recent Developments and Future Plans
 Table 44. Global Aldult CAR T-cell Therapy Revenue (USD Million) by Players (2019-2024)
 Table 45. Global Aldult CAR T-cell Therapy Revenue Share by Players (2019-2024)
 Table 46. Breakdown of Aldult CAR T-cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 47. Market Position of Players in Aldult CAR T-cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 48. Head Office of Key Aldult CAR T-cell Therapy Players
 Table 49. Aldult CAR T-cell Therapy Market: Company Product Type Footprint
 Table 50. Aldult CAR T-cell Therapy Market: Company Product Application Footprint
 Table 51. Aldult CAR T-cell Therapy New Market Entrants and Barriers to Market Entry
 Table 52. Aldult CAR T-cell Therapy Mergers, Acquisition, Agreements, and Collaborations
 Table 53. Global Aldult CAR T-cell Therapy Consumption Value (USD Million) by Type (2019-2024)
 Table 54. Global Aldult CAR T-cell Therapy Consumption Value Share by Type (2019-2024)
 Table 55. Global Aldult CAR T-cell Therapy Consumption Value Forecast by Type (2025-2030)
 Table 56. Global Aldult CAR T-cell Therapy Consumption Value by Application (2019-2024)
 Table 57. Global Aldult CAR T-cell Therapy Consumption Value Forecast by Application (2025-2030)
 Table 58. North America Aldult CAR T-cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 59. North America Aldult CAR T-cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 60. North America Aldult CAR T-cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 61. North America Aldult CAR T-cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 62. North America Aldult CAR T-cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 63. North America Aldult CAR T-cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 64. Europe Aldult CAR T-cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 65. Europe Aldult CAR T-cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 66. Europe Aldult CAR T-cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 67. Europe Aldult CAR T-cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 68. Europe Aldult CAR T-cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 69. Europe Aldult CAR T-cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 70. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 71. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 72. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 73. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 74. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 75. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 76. South America Aldult CAR T-cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 77. South America Aldult CAR T-cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 78. South America Aldult CAR T-cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 79. South America Aldult CAR T-cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 80. South America Aldult CAR T-cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 81. South America Aldult CAR T-cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 82. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 83. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 84. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 85. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 86. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 87. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 88. Global Key Players of Aldult CAR T-cell Therapy Upstream (Raw Materials)
 Table 89. Global Aldult CAR T-cell Therapy Typical Customers


List of Figures
 Figure 1. Aldult CAR T-cell Therapy Picture
 Figure 2. Global Aldult CAR T-cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Aldult CAR T-cell Therapy Consumption Value Market Share by Type in 2023
 Figure 4. CD19
 Figure 5. BCMA
 Figure 6. Others
 Figure 7. Global Aldult CAR T-cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 8. Aldult CAR T-cell Therapy Consumption Value Market Share by Application in 2023
 Figure 9. Multiple Myeloma Picture
 Figure 10. B-Cell Lymphoma (BCL) Picture
 Figure 11. Acute Lymphoblastic Leukemia (ALL) Picture
 Figure 12. Others Picture
 Figure 13. Global Aldult CAR T-cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 14. Global Aldult CAR T-cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 15. Global Market Aldult CAR T-cell Therapy Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 16. Global Aldult CAR T-cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 17. Global Aldult CAR T-cell Therapy Consumption Value Market Share by Region in 2023
 Figure 18. North America Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. South America Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 23. Company Three Recent Developments and Future Plans
 Figure 24. Global Aldult CAR T-cell Therapy Revenue Share by Players in 2023
 Figure 25. Aldult CAR T-cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 26. Market Share of Aldult CAR T-cell Therapy by Player Revenue in 2023
 Figure 27. Top 3 Aldult CAR T-cell Therapy Players Market Share in 2023
 Figure 28. Top 6 Aldult CAR T-cell Therapy Players Market Share in 2023
 Figure 29. Global Aldult CAR T-cell Therapy Consumption Value Share by Type (2019-2024)
 Figure 30. Global Aldult CAR T-cell Therapy Market Share Forecast by Type (2025-2030)
 Figure 31. Global Aldult CAR T-cell Therapy Consumption Value Share by Application (2019-2024)
 Figure 32. Global Aldult CAR T-cell Therapy Market Share Forecast by Application (2025-2030)
 Figure 33. North America Aldult CAR T-cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 34. North America Aldult CAR T-cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 35. North America Aldult CAR T-cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 36. United States Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 37. Canada Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 38. Mexico Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 39. Europe Aldult CAR T-cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 40. Europe Aldult CAR T-cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 41. Europe Aldult CAR T-cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 42. Germany Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 43. France Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 44. United Kingdom Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 45. Russia Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 46. Italy Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 47. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 48. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 49. Asia-Pacific Aldult CAR T-cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 50. China Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 51. Japan Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 52. South Korea Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 53. India Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 54. Southeast Asia Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 55. Australia Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 56. South America Aldult CAR T-cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 57. South America Aldult CAR T-cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 58. South America Aldult CAR T-cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 59. Brazil Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 60. Argentina Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 61. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 62. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 63. Middle East & Africa Aldult CAR T-cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 64. Turkey Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 65. Saudi Arabia Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 66. UAE Aldult CAR T-cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 67. Aldult CAR T-cell Therapy Market Drivers
 Figure 68. Aldult CAR T-cell Therapy Market Restraints
 Figure 69. Aldult CAR T-cell Therapy Market Trends
 Figure 70. Porters Five Forces Analysis
 Figure 71. Aldult CAR T-cell Therapy Industrial Chain
 Figure 72. Methodology
 Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bristol Myers Squibb，BMS
Johnson & Johnson
Gilead Sciences
Novartis
JW Therapeutics
Imunopharm Technology Co., Ltd.
CARsgen Therapeutics
Cartesian Therapeutics

Related Reports

Global Aldult CAR T-cell Therapy Supply, Demand and Key Producers, 2024-2030

Global Aldult CAR T-cell Therapy Supply, Demand and Key Producers, 2024-2030

date 29 Jul 2024

date Service & Software

The global Aldult CAR T-cell Therapy market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

Product Tags

Aldult CAR T-cell Therapy

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>